FORT WASHINGTON, Pa., May 14 PA-RPS-elects-two
FORT WASHINGTON, Pa., May 14 /PRNewswire/ -- RPS, Inc. today announced the
addition of two new members to its Senior Management Team. David A. Green,
Ph.D. joins RPS as Vice President of Clinical Operations. Neil H. Shusterman,
M.D. joins RPS as Senior Vice President, Medical, Regulatory and Drug Safety.
"We are pleased that both Dr. David Green and Dr. Neil Shusterman have
joined the RPS organization. Both individuals bring significant industry and
drug development experience that will further enhance the depth and breadth of
our clinical organizational leadership and expertise," said Harris Koffer,
Pharm.D., President and Chief Operating Officer. "Under their leadership, I am
confident that we will continue to expand our capabilities to provide
innovative, global clinical development solutions to our customers."
David A. Green, Ph.D.
In his new role, Dr. Green will have oversight of Data Management,
Statistics, Programming, Site Management and Monitoring, and Project
Management.
Prior to joining RPS, Dr. Green held numerous positions of increasing
scope and responsibility within the bio-pharmaceutical industry. Most
recently, David served as Executive Director of Clinical Field Operations for
Amgen, Inc. where he led the US Clinical Field Operations and oversaw field
based trial operations across Phase I-III clinical trials and all therapeutic
areas. During his tenure at Amgen he was also the Therapeutic Area Operations
Lead for Diabetes/Obesity, Inflammation, and General Medicine.
David brings over 15 years of clinical trial operations experience in
numerous therapeutic areas primarily associated with Oncology -- Supportive
Care & Therapeutics, Diabetes/Obesity, Inflammation, General Medicine, Bone
Metabolism, and HIV/AIDS. He brings extensive experience in the development
and management of Clinical Field Operations, Clinical Trials Operations, and
Clinical Drug Development in Phases I-III.
Neil H. Shusterman, M.D.
In his new role, Dr. Shusterman will have oversight of Medical, Regulatory
Affairs, Medical Writing and Drug Safety Services.
Prior to joining RPS, Dr. Shusterman was Senior Vice President of Clinical
Development at the Forest Research Institute of Forest Laboratories, Inc. At
Forest Laboratories he also served as Senior Vice President, Clinical
Development, Safety and Operations and Vice President, Internal Medicine
Therapeutic Area, Clinical Development and Medical Affairs. Before joining
Forest, Dr. Shusterman held the position of Vice President, Cardiovascular
Therapeutic Area, North American Medical Affairs, R&D, at GlaxoSmithKline. He
brings extensive knowledge and experience in clinical research and
development, as well as therapeutic expertise in internal medicine, nephrology
and cardiovascular medicine.
Additionally, Dr. Shusterman has served as an adjunct Assistant Professor
in the Department of Medicine at the University of Pennsylvania's School of
Medicine in Philadelphia, PA, and has held Administrative Appointments such as
Chief Executive Officer, University of Pennsylvania Outpatient Dialysis Unit.
He is board certified in Internal Medicine and Nephrology.
About RPS
RPS (ReSearch Pharmaceutical Services, Inc.), The Next Generation CRO,
provides comprehensive global Phase I-IV clinical development solutions to the
Pharmaceutical, Biotechnology and Medical Device industries. By combining an
experienced clinical research operations infrastructure with the industry's
largest resourcing engines, RPS is uniquely positioned to offer our clients
both integrated and full service global outsourcing solutions.
SOURCE ReSearch Pharmaceutical Services, Inc.
